Headline News

 

Roche signs definitive merger agreement to buy PathAI in bid to advance AI-powered diagnostics

Posted on May 11, 2026

Johnson & Johnson launches Generation Fine, a new movement encouraging patients to expect more from depression treatment and aim for remission

Posted on May 11, 2026

Thermo Fisher Scientific’s clinical research business named a leader among CROs in 2026 ISG Provider Lens report for use of AI in clinical trials

Posted on May 11, 2026

Lilly’s Omvoh is the first IL-23p19 to demonstrate durable disease clearance in ulcerative colitis through four years

Posted on May 11, 2026

CNS drug delivery breakthroughs unlock significant biotech market opportunities

Posted on May 11, 2026

GSK partners with SBP Group to accelerate bepirovirsen launch across China

Posted on May 11, 2026

Avalo Therapeutics hits primary endpoint in Phase 2 hidradenitis suppurativa trial

Posted on May 11, 2026

Cytokinetics hits on both primary endpoints in pivotal non-obstructive HCM trial

Posted on May 11, 2026

Bayer to acquire Perfuse Therapeutics in bid to lead ophthalmology pipeline

Posted on May 11, 2026

Madrigal bolsters MASH pipeline with Arrowhead’s PNPLA3-targeting siRNA

Posted on May 11, 2026

Johnson & Johnson’s Tremfya becomes first IL-23 inhibitor to demonstrate efficacy in perianal fistulizing Crohn’s disease

Posted on May 05, 2026

Johnson & Johnson’s JNJ-4804 shows promising Phase 2b results in refractory inflammatory bowel disease

Posted on May 05, 2026

Bristol Myers Squibb launches “Won’t Lose” campaign ahead of FIFA World Cup 2026

Posted on May 05, 2026

GSK’s bepirovirsen granted priority review and breakthrough therapy designation by FDA for chronic hepatitis B

Posted on May 05, 2026

AstraZeneca’s Breztri approved in the US for asthma, becoming the first and only single-inhaler triple therapy for patients aged 12 and older

Posted on May 05, 2026